Edesa Biotech, .

Edesa Biotech, .Edesa Biotech, .
Edesa Biotech, .

Edesa Biotech, .

Edesa Biotech is a clinical-stage biopharmaceutical company focused on developing innovative treatments for inflammatory and immune-related diseases.

Website
Active23
Rate
Advertise here

About

Edesa Biotech is a clinical-stage biopharmaceutical company dedicated to identifying, developing, and commercializing innovative therapies for inflammatory and immune-related diseases. Their pipeline includes drug candidates for conditions such as chronic rhinosinusitis with nasal polyps, vitiligo, and other dermatological and gastrointestinal inflammatory disorders, aiming to address unmet medical needs.

Technology stack

detected 2026-07-07
EmailBarracuda
gateway-fronted
Hosting
self_managed
Stack
jQueryWordPress
Analytics
Google Analytics 4
Compliance
GDPRCCPA
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does Edesa Biotech, . do?

Edesa Biotech is a clinical-stage biopharmaceutical company dedicated to identifying, developing, and commercializing innovative therapies for inflammatory and immune-related diseases. Their pipeline includes drug candidates for conditions such as chronic rhinosinusitis with nasal polyps, vitiligo, and other dermatological and gastrointestinal inflammatory disorders, aiming to address unmet medical needs.

Where is Edesa Biotech, . headquartered?

Edesa Biotech, . is headquartered in Markham, Canada.

What industry does Edesa Biotech, . operate in?

Edesa Biotech, . operates in Biotech, MedTech, Drug Discovery, Clinical Trials, Inflammatory Diseases, Immunology.

How many employees does Edesa Biotech, . have?

Edesa Biotech, . has approximately 23 people on record.

What is Edesa Biotech, .'s revenue?

StartupHub estimates Edesa Biotech, .'s annual revenue at $2.8M (range $1.5M to $9.3M, 65% confidence), based on comparable companies in the sector.